Statins Decrease the Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: A Population-Based Study

Hepatology - United States
doi 10.1002/hep.29172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Reply: Statins Decrease the Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: A Population-Based Study

Hepatology
MedicineHepatology
2018English

Statins and Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: Methodological Issues

Hepatology
MedicineHepatology
2018English

Hepatitis C Virus Infection and Risk of Cancer: A Population-Based Cohort Study

Clinical Epidemiology
Epidemiology
2010English

Maternal Hepatitis B Virus or Hepatitis C Virus Carrier Status and Long-Term Endocrine Morbidity of the Offspring—A Population-Based Cohort Study

Journal of Clinical Medicine
2020English

Seroprevalance of Hepatitis B Virus, Human Immunodeficiency Virus and Hepatitis C Virus Among Blood Donors: A Retrospective Study

Tropical Journal of Pathology and Microbiology
2019English

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection

International Journal of Medical Sciences
Medicine
2006English

Statin and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis

BMC Gastroenterology
MedicineGastroenterology
2020English

Hepatocellular Carcinoma Complicating Hepatitis E Virus-Related Cirrhosis

Hepatology
MedicineHepatology
2017English

Detection of Hepatitis Virus B and C in Archival Autopsy Specimens of Liver Cirrhosis

Biomedical Journal of Scientific & Technical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy